1. Identification of Five Immune-Related lncRNAs Predicting Survival and Tumor Microenvironment Characteristics in Breast Cancer
   Ran Xiao et al, 2021, Computational and Mathematical Methods in Medicine CrossRef
2. NUSAP1 and PCLAF (KIA0101) Downregulation by Neoadjuvant Therapy is Associated with Better Therapeutic Outcomes and Survival in Breast Cancer
   Gerardo I. Magallanes-Garza et al, 2022, Journal of Oncology CrossRef
3. An Immunohistochemical Study of β-catenin Expression and Immune Cell Population in Metastatic Carcinoma to the Liver
   Kwan-Yung Au et al, 2021, Pathology and Oncology Research CrossRef
4. Prognostic value of various immune cells and Immunoscore in triple-negative breast cancer
   Xinyu Ren et al, 2023, Frontiers in Immunology CrossRef
5. Characterisation of luminal and triple-negative breast cancer with HER2 Low protein expression
   Nehal M. Atallah et al, 2023, European Journal of Cancer CrossRef
6. Early Detection and Investigation of Extracellular Vesicles Biomarkers in Breast Cancer
   Erika Bandini et al, 2021, Frontiers in Molecular Biosciences CrossRef
7. PP2A as a potential therapeutic target for breast cancer: Current insights and future perspectives
   Yalong Qi et al, 2024, Biomedicine & Pharmacotherapy CrossRef
8. Triple negative breast cancer: Immunogenicity, tumor microenvironment, and immunotherapy
   Sotiris Loizides et al, 2023, Frontiers in Genetics CrossRef
9. Tumor Suppressive Role of MicroRNAs in Triple Negative Breast Cancer
   Acharya Balkrishna et al, 2023, Current Pharmaceutical Design CrossRef
10. Multiomics technologies for comprehensive tumor microenvironment analysis in triple-negative breast cancer under neoadjuvant chemotherapy
    Gang Wang et al, 2023, Frontiers in Oncology CrossRef
11. Early-stage triple negative breast cancer: the therapeutic role of immunotherapy and the prognostic value of pathological complete response
    Pierluigi De Santis et al, 2024, Exploration of Targeted Anti-tumor Therapy CrossRef
12. Low-risk triple-negative breast cancers: Clinico-pathological and molecular features
    Nicola Fusco et al, 2022, Critical Reviews in Oncology/Hematology CrossRef